Intervention not reportedWHO/NYHA functional class · patients with pulmonary hypertension secondary to systemic scleroderma.1 finding from 1 reviewCalcium channel blockers for pulmonary arterial hypertension 2015 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedVery low